Countdown to Amdocs (DOX) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Zacks
07 Nov 2024

Wall Street analysts forecast that Amdocs (DOX) will report quarterly earnings of $1.70 per share in its upcoming release, pointing to a year-over-year increase of 19.7%. It is anticipated that revenues will amount to $1.27 billion, exhibiting an increase of 1.9% compared to the year-ago quarter.

Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.2% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.

Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.

While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.

Given this perspective, it's time to examine the average forecasts of specific Amdocs metrics that are routinely monitored and predicted by Wall Street analysts.

Analysts' assessment points toward 'Revenue- Managed Services Revenue' reaching $749.54 million. The estimate suggests a change of +4.4% year over year.

It is projected by analysts that the 'Geographic Revenue- North America' will reach $844.84 million. The estimate points to a change of +1.3% from the year-ago quarter.

The combined assessment of analysts suggests that 'Geographic Revenue- Rest of the world' will likely reach $240.67 million. The estimate indicates a year-over-year change of +3.5%.

The consensus estimate for 'Geographic Revenue- Europe' stands at $185.06 million. The estimate indicates a change of +5.5% from the prior-year quarter.

View all Key Company Metrics for Amdocs here>>>

Over the past month, Amdocs shares have recorded returns of +3.3% versus the Zacks S&P 500 composite's +3.2% change. Based on its Zacks Rank #4 (Sell), DOX will likely underperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Amdocs Limited (DOX) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10